Comparing immune responses in bacterial vs. COVID-19 sepsis
Part of Infections, Lungs & breathing clinical trials.
This study compares how the body's immune system responds to bacterial sepsis vs. viral sepsis (COVID-19) in intensive care unit patients. The goal is to find better ways to treat each type of life-threatening infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sepsis (a severe infection that causes your body to attack itself).
- Your infection is either bacterial (confirmed by culture) or viral (specifically COVID-19, confirmed by a PCR test).
- You are 18 years or older.
- You are currently admitted to the intensive care unit (ICU).
- You do not have both a bacterial and viral infection (mixed infection).
- You have not received any immune-modifying drugs (other than standard treatments).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.